Candel Therapeutics Inc (CADL)
Healthcare
Biotechnology
10.00 $
+1.4%
vs. previous close
Closing price · As of: 31. Jul 2026
Candel Therapeutics Inc (CADL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -18 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.2 | -8.8 | -7.4 | -8.4 | -6.2 | -6.6 | -5.8 | -8.6 | -8.9 | -10 | -11 | -18 | -48 | |
| 0.2 | 0.2 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.7 | |
| 0.7 | 0.7 | 0.9 | 1.0 | 1.8 | 1.2 | 1.2 | 0.3 | 1.1 | 1.2 | 1.3 | 1.5 | 5.0 | |
| 0.7 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 1.4 | -1.1 | 1.6 | -1.7 | 0.4 | 0.8 | 0.7 | -1.8 | 0.1 | 0.4 | 3.6 | -3.6 | 0.4 | |
| 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.4 | 0.7 | 1.3 | |
| -0.2 | -0.1 | – | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | -0.1 | -0.4 | -0.7 | -1.2 | |
| – | – | -0.1 | -0.1 | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -2.5 | -2.5 | -2.5 | -2.5 | -2.5 | 44 | 0.0 | 39 | |
| 0.0 | 0.0 | -0.1 | -1.3 | 1.9 | 1.7 | 92 | -1.9 | 17 | -3.4 | 44 | 94 | 152 | |
| -7.4 | -8.9 | -7.6 | -9.7 | -4.3 | -4.9 | 86 | -10 | 8.5 | -14 | 33 | 75 | 103 | |
| -7.4 | -8.9 | -7.5 | -8.4 | -6.2 | -6.6 | -5.8 | -8.6 | -8.9 | -10 | -11 | -19 | -49 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.